1. Home
  2. ASRT vs AVTX Comparison

ASRT vs AVTX Comparison

Compare ASRT & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • AVTX
  • Stock Information
  • Founded
  • ASRT 1995
  • AVTX 2011
  • Country
  • ASRT United States
  • AVTX United States
  • Employees
  • ASRT N/A
  • AVTX N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • AVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASRT Health Care
  • AVTX Health Care
  • Exchange
  • ASRT Nasdaq
  • AVTX Nasdaq
  • Market Cap
  • ASRT 85.1M
  • AVTX 88.4M
  • IPO Year
  • ASRT 1997
  • AVTX 2015
  • Fundamental
  • Price
  • ASRT $0.80
  • AVTX $8.18
  • Analyst Decision
  • ASRT Strong Buy
  • AVTX Strong Buy
  • Analyst Count
  • ASRT 4
  • AVTX 4
  • Target Price
  • ASRT $3.19
  • AVTX $33.00
  • AVG Volume (30 Days)
  • ASRT 357.9K
  • AVTX 65.8K
  • Earning Date
  • ASRT 03-10-2025
  • AVTX 03-28-2025
  • Dividend Yield
  • ASRT N/A
  • AVTX N/A
  • EPS Growth
  • ASRT N/A
  • AVTX N/A
  • EPS
  • ASRT N/A
  • AVTX N/A
  • Revenue
  • ASRT $125,763,000.00
  • AVTX $820,000.00
  • Revenue This Year
  • ASRT N/A
  • AVTX N/A
  • Revenue Next Year
  • ASRT $1.84
  • AVTX N/A
  • P/E Ratio
  • ASRT N/A
  • AVTX N/A
  • Revenue Growth
  • ASRT N/A
  • AVTX N/A
  • 52 Week Low
  • ASRT $0.73
  • AVTX $4.17
  • 52 Week High
  • ASRT $1.80
  • AVTX $34.46
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 43.92
  • AVTX 52.50
  • Support Level
  • ASRT $0.78
  • AVTX $7.82
  • Resistance Level
  • ASRT $0.83
  • AVTX $8.50
  • Average True Range (ATR)
  • ASRT 0.03
  • AVTX 0.78
  • MACD
  • ASRT 0.00
  • AVTX 0.20
  • Stochastic Oscillator
  • ASRT 39.86
  • AVTX 73.11

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

Share on Social Networks: